Task: Answer Verification
Input (English): Question: Does elevated body mass index increase the risk of palmar-plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicin?
Answer: Elevated BMI does not appear to correlate with occurrence of PPE in our population. Of interest, among patients discontinuing PLD due to skin toxicity, 25% had clinical evidence of response. The identification of predisposing risk factors may help guide treatment decisions; however, elevated BMI does not appear to be such a risk factor.
Output (English): no